Trump may be mystery patient in odd case of 79yo getting experimental obesity drug
7 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"Trump may be mystery patient in odd case of 79yo getting experimental obesity drug" is generating significant coverage in the Business category, with 9 articles from 7 distinct sources tracked by PULSE so far.
Outlets currently covering the story include The New Republic, The Daily Beast, Mother Jones and Forbes. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 145d ago.
Quick answers
Why is "Trump may be mystery patient in odd case of 79yo getting experimental obesity dr" trending?
Because 7 independent news sources published 9 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (9)
- Eli Lilly Approved Obesity Drug for Mystery 79-Year-Old Patient The New Republic · 147d ago
- White House Cornered on Identity of Patient, 79, Given Special Weight Loss Drug The Daily Beast · 147d ago
- Did Trump Get Special Access to Retatrutide? Mother Jones · 147d ago
- White House Denies Trump Was Given Exclusive Weight Loss Drug Forbes · 147d ago
- Remember That Time Trump Said He “Probably Should” Take Ozempic? The New Republic · 147d ago
- Lilly allows one-time access to next-gen obesity drug (update) Seeking Alpha · 147d ago
- Lilly’s retatrutide has been offered to a single person via ‘compassionate use’ program statnews.com · 147d ago
- Eli Lilly gave extraordinary obesity drug access to a 79-year-old patient. Who was it? statnews.com · 147d ago
- Trump may be mystery patient in odd case of 79yo getting experimental obesity drug Ars Technica · 147d ago
Topics
Related trends
Trump’s pick for Navy secretary acknowledges the Iran war is straining military resources
Trump Navy secretary nominee Hung Cao tells Senate panel the Iran war is stretching fleet capacity and personnel to the breaking point.
Trump Returns With a Bizarre Pile of Fluff on His Head After Absence
Recent coverage focuses on remarks directed at a reporter regarding Iran threat concerns and subsequent analytical commentary.
Nvidia Forms Export Control Board Committee After Chip Curbs
Nvidia creates a board-level national security and export control oversight committee following scrutiny over China chip sales and leadership changes.
Trump arrives in Philippines to kick off Asia trip with economic deals and talks with allies
US President Donald Trump has arrived in the Philippines for the first leg of his trip to Asia.
Xi says Asia-Pacific needs open trade and Putin condemns sanctions as Trump arrives in China
Leaders gather at the Apec summit as diplomatic events unfold with talks between Xi and Putin alongside Trump's arrival in China.
China’s Xi and other Asian leaders say Asia-Pacific must embrace open trade, fair growth
Leaders gather at the Apec summit as bilateral talks begin and diplomatic discussions unfold regarding international meetings.